Symberix Email Formats	Example	Percentage
First.Last@symberix.com	John.Doe@symberix.com	50%
First.Last@symberix.com	John.Doe@symberix.com	50%

Where is Symberix's headquarters located?

Symberix's main headquarters is located at 4819 Emperor Blvd. 400 Research Triangle Park, NC 27703 US. The company has employees across 1 continents, including North America.

What is Symberix's official website and social media links?

Symberix's official website is symberix.com and has social profiles on LinkedIn.

What is Symberix's SIC code NAICS code?

Symberix's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Symberix have currently?

As of August 2023, Symberix has approximately 5 employees across 1 continents, including North America. Key team members include President And Ceo: W. P.Co Founder And Chief Scientific Officer: M. R.Director: B. W.. Explore Symberix's employee directory with LeadIQ.

What industry does Symberix belong to?

Symberix operates in the Biotechnology Research industry.

What technology does Symberix use?

Symberix's tech stack includes jQuery.

What is Symberix's email format?

Symberix's email format typically follows the pattern of . Find more Symberix email formats with LeadIQ.

When was Symberix founded?

Symberix was founded in 2013.

Symberix

Biotechnology ResearchNorth Carolina, United States2-10 Employees

Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them. Symberix’s scientific founder, Matthew Redinbo, PhD, was the first to demonstrate the feasibility of therapeutically controlling the mammalian microbiome with small-molecule symbiotic drugs. Based on this breakthrough research, the company is advancing a first-in-class approach to improve the treatment of serious lower gastrointestinal (GI) diseases as well as mitigate the debilitating lower GI side effects associated with various cancer, pain, and immunosuppressive therapies. Symberix’s internal team and scientific/clinical/business advisors have a deep understanding of the microbiome as well as extensive drug discovery, clinical development and commercial biopharma experience. Our vision: Safe and effective pharmaceutical control of the microbiome.